Quantum Biopharma Ltd QNTM

$3.42 -0.18 (-5.00%)

Valuation

Market cap
29,115,000
Revenue TTM
$0
Net income TTM
$-26,180,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
82,600
Avg volume
222,664
Day's range
$3.40 – $3.66
Shares out
8,087,000
Stochastic %K
3%
Beta
0.45
Analysts
Strong Sell
Price target
$21.75

Price

Company profile

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of de...

Show more

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company's lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. It also develops FSD-PEA, which is in preparation for Phase 2 trial for the treatment of inflammatory diseases, such as mast cell activation syndrome; Lucid-PSYCH to treat major depressive disorder; and unbuzzd, a dietary supplement for the treatment of alcohol misuse. In addition, the company maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd. was founded in 1998 and is based in Toronto, Canada.

Industry
Biotechnology
Sector
Healthcare
Phone
833 571 1811
Website
https://www.quantumbiopharma.com
Address
1 Adelaide Street East, Suite 801, Toronto, Canada

Latest news

Stocktwits

James23db Oct 1, 9:17 PM
$GNS $QNTM holy crap these suck
1 replies
FickleFin Oct 1, 12:14 PM
$QNTM $GNS VS. RETAIL. IYKYK. Look... a shout out to HAMNAKEDSHORTS and MALONE and friends. 🥴🤡 Patting each on the back for doing nothing...
0 replies
FickleFin Oct 1, 3:19 AM
$QNTM company isnt even established and did a 1 for 24 Reverse split... 😄😄😄
0 replies
FickleFin Oct 1, 12:14 AM
$QNTM your hoping for a monkey see monket do situation. Quantum Biopharma Current lawsuit motion to lead plaintiff. DENIED. $GNS genius group vs citadel
0 replies
Rambler1111 Sep 30, 10:55 PM
$QNTM Watch GNS and watch QNTM mirror what GNS does. Getting really good.
0 replies
NetworkNewsWire Sep 30, 2:43 PM
BioMedNewsBreaks — $QNTM $QNTM.CN Co-Founder Discusses Lucid-MS Phase 2 Program, unbuzzd(TM) in BioMedWire Podcast https://ibn.fm/ovRTM
0 replies
James23db Sep 30, 2:08 PM
$QNTM back to $2’s? im confused
0 replies
FickleFin Sep 30, 1:13 PM
$GNS $MMTLP $NWBO $QNTM Shito after shitco after shitco after shitco...
1 replies